A CK2-dependent mechanism for degradation of the PML tumor suppressor
about
PML nuclear bodiesCoordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR elementPharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia proteinThe SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARAFunctional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancerSUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PMLTRIM family proteins and their emerging roles in innate immunityMisregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasionThe function, regulation and therapeutic implications of the tumor suppressor protein, PMLRegulation of Bim in Health and DiseaseThe cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodiesContributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survivalProtein kinase CK2 and human malignant tumorsStructural basis for catalytic activation by the human ZNF451 SUMO E3 ligaseArsenic induces polyadenylation of canonical histone mRNA by down-regulating stem-loop-binding protein gene expressionAdenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cellsCK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis.Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradationCasein kinase 2 dependent phosphorylation of neprilysin regulates receptor tyrosine kinase signaling to AktPromyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.Inhibition of casein kinase 2 blocks G2/M transition in early embryo mitosis but not in oocyte meiosis in mouseOverexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer.Downregulation of protein kinase CK2 activity facilitates tumor necrosis factor-α-mediated chondrocyte death through apoptosis and autophagy.SUMOylation promotes PML degradation during encephalomyocarditis virus infection.Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cellsPML-mediated signaling and its role in cancer stem cells.Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2.Hybrid detectors improved time-lapse confocal microscopy of PML and 53BP1 nuclear body colocalization in DNA lesions.PML targeting eradicates quiescent leukaemia-initiating cells.Phosphorylation by CK2 enhances the rapid light-induced degradation of phytochrome interacting factor 1 in ArabidopsisA Phospho-SIM in the Antiviral Protein PML is Required for Its Recruitment to HSV-1 Genomes.Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylationA Role for PML in Innate ImmunityA CK2-dependent mechanism for activation of the JAK-STAT signaling pathway.CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.Protein kinase CK2 in health and disease: CK2: a key player in cancer biology
P2860
Q22065791-B939487B-0890-485A-BD70-1832B8F57EB1Q24295165-AF91D1D6-1C29-4AB7-96DD-8BCA0B54CFBAQ24299360-B7760EA7-004F-4123-A0C7-399AFB31B874Q24307375-540F3BFF-4206-45F8-A2E5-4705F5C4CAE3Q24338701-955D7DDF-69F4-42A0-8559-70D1C12F759DQ24338995-EE3B77E4-93E7-47D3-B0A1-87FDF598941CQ24607229-2D17E4DB-B5D3-453A-80B8-C065B4EB8045Q26766056-B74CB9B3-A968-4578-A77E-73830789E8AAQ26779358-70BAD8A9-3D7A-4681-A425-34C02D40884AQ26781203-22CB0F4D-58A9-4706-907A-F0EC88564122Q26853348-E69443CD-1700-4161-A79E-6EFE100DCB2FQ27003831-DB110D20-9D10-4932-A764-FC3315B0BB5FQ27026335-34BE5A31-DFC1-4D17-9268-F0EE32FDF765Q28115051-4C10E8ED-5E38-4326-A333-8D478F8FF8C7Q28397679-78A88D04-F0E1-41F7-8E39-3EA724B8FEB3Q28574947-BF1561F8-BF2A-4DE3-BC18-802EF4EA3664Q30277146-7459CB8B-03CC-4A68-AB38-98660897A487Q30482510-2C6E07CC-F6AB-459D-BDE6-FBB44F0466E4Q33373662-BF550022-37E7-40B3-A7DE-A3A555BD2EC2Q33575096-7F038866-AE1E-44DB-B302-E6596C001007Q33721897-2449C718-A9A3-4C80-8C5E-9716DF64E754Q33744538-160335AC-BEAC-4B83-B598-89EF5544B859Q33815705-D614A584-BE29-4BD8-979F-D23F2E2BB5DDQ33824136-56C78DF6-B630-4C43-9893-CDAACC4AC54AQ33826714-1A1F5FFE-F5E0-4407-B202-AD45DDA65F36Q33832029-EED674F2-B54C-4F2A-B99F-D6FF079C05F0Q33895200-4BE52E13-EEE1-4505-B6E4-166E6F14F67FQ34295991-49627662-EC21-4977-BDFC-AB60CA69148CQ34328051-33BADDF0-773E-4835-BA9C-2B53529BDD3EQ34337626-D460958B-C723-4D88-B57C-8FEC9831B697Q34573044-9AEC2AC3-63F6-48AB-B0B5-CF4EFDD06180Q34587697-B8915421-F680-4E68-B615-18B4A69DE4CFQ34591761-1FD32068-DFE8-43EB-ADCB-8350521606F2Q34752055-624C94C5-BC44-452E-86AD-408A1DA48AA7Q34774721-B8516C30-D651-470C-AF41-72B78AA85417Q34994567-E907E5EF-A983-4CDA-A6FD-223DE6E4BAAAQ35034064-44325BBB-D9DB-4C86-833E-D1826E0DEF43Q35114492-3F7BC5A7-2538-4DF9-A676-C04199B34048Q35175764-4B2DC137-BE47-4759-8C2A-6682E33DA516Q35270830-C674ECF0-58DA-4D68-9231-087DA4E4BE69
P2860
A CK2-dependent mechanism for degradation of the PML tumor suppressor
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@ast
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@en
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@en-gb
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@nl
type
label
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@ast
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@en
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@en-gb
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@nl
prefLabel
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@ast
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@en
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@en-gb
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@nl
P2093
P50
P1433
P1476
A CK2-dependent mechanism for degradation of the PML tumor suppressor
@en
P2093
Andrew J Kaufman
Bhuvanesh Singh
Lu Fan Cai
Thomas M Yung
P304
P356
10.1016/J.CELL.2006.05.041
P407
P577
2006-07-28T00:00:00Z